<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0020">
 <label>20</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Jaballah</surname>
    <given-names>MY</given-names>
   </name>, 
   <name name-style="western">
    <surname>Serya</surname>
    <given-names>RT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Abouzid</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Pyridazine based scaffolds as privileged structures in anti-cancer therapy</article-title>. 
  <source>Drug Res (Stuttg)</source>
  <year>2017</year>;
  <volume>67</volume>:
  <fpage>138</fpage>â€“
  <lpage>48</lpage>.
  <pub-id pub-id-type="pmid">28073115</pub-id>
 </mixed-citation>
</ref>
